Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-21-030818

Options or other derivatives

  • Chief Executive Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. Chief Executive Officer 2021-12-07 Grant or award · Stock Option (Right to Buy) +125,000 $1.12 $140,000 125,000 D
Loading xslF345X03/ownership.xml…